查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1467874

2024-2032 年按產品、產業、應用、最終用戶和地區分類的血漿分餾市場報告

Plasma Fractionation Market Report by Product, Sector, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球血漿分離市場規模達到251億美元。

血漿分餾是指將捐贈的血漿下游加工成挽救生命的療法和藥品。它使用機械分離方法（例如離心、深度過濾、沉澱和色譜法）將血漿分解成單獨的蛋白質或血漿組分。如今，一些現代分餾過程使用酒精濃度、時間、溫度和 pH 值來提取特定的治療性蛋白質。此外，多年來技術複雜性的增加以及過程中病毒減少治療的引入導致了新的蛋白質療法的開發以及產品純度和品質的提高。

血漿分餾市場趨勢：

從人類血漿中分離的蛋白質產品是一類重要的治療藥物，廣泛用於預防、管理和治療危及生命的疾病，例如感染、先天性缺陷、罕見血液疾病、免疫疾病和自體免疫疾病。全球很大一部分人口中這些疾病的盛行率顯著上升，這是推動市場成長的關鍵因素之一。此外，由於許多國家的管理機構對生物製品的品質保證實施了嚴格的法規和標準控制和設置，製造商正在開發具有額外安全功能的血漿分級分離。除此之外，市場參與者正在資助研發 (R&D) 活動，以推動血漿生產技術的進步，以提高產品功效並提高免疫球蛋白 G (IgG) 的回收率，以分離新的血漿蛋白。此外，他們也致力於開發經濟實惠的病毒去活化和加工技術，以安全地利用當地血漿資源。再加上提高產量、維持製程經濟性和管理日益嚴格的監管要求的需求不斷增加，預計將在未來幾年提供有利的市場前景。

本報告回答的關鍵問題

  • 2023 年全球血漿分離市場規模有多大？
  • 2024-2032年全球血漿分離市場的預期成長率是多少？
  • COVID-19 對全球血漿分離市場有何影響？
  • 推動全球血漿分離市場的關鍵因素是什麼？
  • 基於該產品的全球血漿分離市場的詳細情形如何？
  • 全球血漿分離市場依產業分類是怎樣的？
  • 基於應用的全球血漿分離市場的細分如何？
  • 基於最終用戶的全球血漿分離市場的詳細情形如何？
  • 全球血漿分離市場的關鍵區域有哪些？
  • 全球血漿分離市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球血漿分餾市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 免疫球蛋白
    • 市場走向
    • 市場預測
  • 白蛋白
    • 市場走向
    • 市場預測
  • 凝血因子VIII
    • 市場走向
    • 市場預測
  • 凝血因子IX
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依行業

  • 私部門
    • 市場走向
    • 市場預測
  • 公部門
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按應用

  • 神經病學
    • 市場走向
    • 市場預測
  • 免疫學
    • 市場走向
    • 市場預測
  • 血液學
    • 市場走向
    • 市場預測
  • 其他應用
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 醫院和診所
    • 市場走向
    • 市場預測
  • 臨床研究實驗室
    • 市場走向
    • 市場預測
  • 學術機構
    • 市場走向
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • ADMA Biologics
    • Bio Products Laboratory Ltd.
    • Boccard
    • Grifols, SA
    • Hemarus Therapeutics Limited
    • Intas Pharmaceuticals Limited
    • LFB SA
    • Merck Group
    • Octapharma AG
    • PlasmaGen BioSciences Pvt. Ltd.
    • SK Plasma Co. Ltd.
    • Virchow Biotech Private Limited
Product Code: SR112024A5973

The global plasma fractionation market size reached US$ 25.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032.

Plasma fractionation refers to the downstream processing of donated plasma into life-saving therapies and medicinal products. It breaks plasma into individual proteins or plasma fractions using mechanical separation methods, such as centrifugation, depth filtration, precipitation, and chromatography. Nowadays, several modern fractionation processes use alcohol concentrations, time, temperature, and pH to extract specific therapeutic proteins. Moreover, increasing technology complexity over the years and the introduction of in-process viral reduction treatments have resulted in the development of new protein therapeutics and improvement in product purity and quality.

Plasma Fractionation Market Trends:

Protein products fractionated from human plasma are an essential class of therapeutics widely used to prevent, manage, and treat life-threatening conditions, such as infections, congenital deficiencies, rare blood disorders, immunologic disorders, and autoimmune disorders. A significant rise in the prevalence of these conditions among a significant part of the population globally represents one of the key factors impelling the market growth. In addition, manufacturers are developing plasma fractionation with additional safety features due to the implementation of stringent regulations and standard controls and settings by governing agencies of numerous countries on quality assurance of biological products. Apart from this, market players are financing research and development (R&D) activities to launch advancement in plasma production technology to improve product efficacy and enhance recovery of immunoglobulin G (IgG) to isolate new plasma proteins. Furthermore, they are focusing on developing affordable viral inactivation and processing technologies that allow utilization of local plasma resources safely. This, in confluence with the escalating need to improve yield, maintain process economics, and manage increasing regulatory requirements, is anticipated to provide a favorable market outlook in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global plasma fractionation market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, sector, application and end user.

Breakup by Product:

Immunoglobulins

Albumin

Coagulation factor VIII

Coagulation factor IX

Breakup by Sector:

Private Sector

Public Sector

Breakup by Application:

Neurology

Immunology

Hematology

Other Applications

Breakup by End User:

Hospitals and Clinics

Clinical Research Laboratories

Academic Institutes

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ADMA Biologics, Bio Products Laboratory Ltd., Boccard, Grifols, S.A., Hemarus Therapeutics Limited, Intas Pharmaceuticals Limited, LFB S.A., Merck Group, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., SK Plasma Co. Ltd. and Virchow Biotech Private Limited.

Key Questions Answered in This Report

  • 1. What was the size of the global plasma fractionation market in 2023?
  • 2. What is the expected growth rate of the global plasma fractionation market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global plasma fractionation market?
  • 4. What are the key factors driving the global plasma fractionation market?
  • 5. What is the breakup of the global plasma fractionation market based on the product?
  • 6. What is the breakup of the global plasma fractionation market based on the sector?
  • 7. What is the breakup of the global plasma fractionation market based on the application?
  • 8. What is the breakup of the global plasma fractionation market based on the end user?
  • 9. What are the key regions in the global plasma fractionation market?
  • 10. Who are the key players/companies in the global plasma fractionation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Plasma Fractionation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Immunoglobulins
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Albumin
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Coagulation factor VIII
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Coagulation factor IX
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Sector

  • 7.1 Private Sector
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Public Sector
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Neurology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Immunology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hematology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Other Applications
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinical Research Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 ADMA Biologics
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Bio Products Laboratory Ltd.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Boccard
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Grifols, S.A.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Hemarus Therapeutics Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Intas Pharmaceuticals Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 LFB S.A.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Merck Group
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Octapharma AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 SWOT Analysis
    • 15.3.10 PlasmaGen BioSciences Pvt. Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 SK Plasma Co. Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Virchow Biotech Private Limited
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Plasma Fractionation Market: Major Drivers and Challenges
  • Figure 2: Global: Plasma Fractionation Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Plasma Fractionation Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Plasma Fractionation Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Plasma Fractionation Market: Breakup by Sector (in %), 2023
  • Figure 6: Global: Plasma Fractionation Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Plasma Fractionation Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Plasma Fractionation Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Plasma Fractionation (Immunoglobulins) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Plasma Fractionation (Immunoglobulins) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Plasma Fractionation (Albumin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Plasma Fractionation (Albumin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Plasma Fractionation (Coagulation factor VIII) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Plasma Fractionation (Coagulation factor VIII) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Plasma Fractionation (Coagulation factor IX) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Plasma Fractionation (Coagulation factor IX) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Plasma Fractionation (Private Sector) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Plasma Fractionation (Private Sector) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Plasma Fractionation (Public Sector) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Plasma Fractionation (Public Sector) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Plasma Fractionation (Neurology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Plasma Fractionation (Neurology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Plasma Fractionation (Immunology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Plasma Fractionation (Immunology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Plasma Fractionation (Hematology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Plasma Fractionation (Hematology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Plasma Fractionation (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Plasma Fractionation (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Plasma Fractionation (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Plasma Fractionation (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Plasma Fractionation (Clinical Research Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Plasma Fractionation (Clinical Research Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Plasma Fractionation (Academic Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Plasma Fractionation (Academic Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: North America: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: North America: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: United States: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: United States: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Canada: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Canada: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Asia-Pacific: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Asia-Pacific: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: China: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: China: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Japan: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Japan: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: India: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: India: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: South Korea: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: South Korea: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Australia: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Australia: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Indonesia: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Indonesia: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Others: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Others: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Europe: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Europe: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Germany: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Germany: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: France: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: France: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: United Kingdom: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: United Kingdom: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Italy: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Italy: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Spain: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Spain: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Russia: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Russia: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Latin America: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Latin America: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Brazil: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Brazil: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Mexico: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Mexico: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Others: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Others: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Middle East and Africa: Plasma Fractionation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Middle East and Africa: Plasma Fractionation Market: Breakup by Country (in %), 2023
  • Figure 83: Middle East and Africa: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Global: Plasma Fractionation Industry: SWOT Analysis
  • Figure 85: Global: Plasma Fractionation Industry: Value Chain Analysis
  • Figure 86: Global: Plasma Fractionation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Plasma Fractionation Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Plasma Fractionation Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Plasma Fractionation Market Forecast: Breakup by Sector (in Million US$), 2024-2032
  • Table 4: Global: Plasma Fractionation Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Plasma Fractionation Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Plasma Fractionation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Plasma Fractionation Market: Competitive Structure
  • Table 8: Global: Plasma Fractionation Market: Key Players